Epoch Biosciences (EBIO) Inactive 10-Q2004 Q1 Quarterly report

Filed: 11 May 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: accredited, adhere, agent, analyte, April, attention, Biosystem, calculation, Celera, chart, civil, clearance, CLIA, closed, closing, complexity, comply, criminal, declared, degree, depreciation, devote, diagnostic, directly, distributor, dollar, Draft, EclipseBy, EITF, exempt, exemption, expansion, FDA, home, implement, implementation, imposed, Indexed, indirect, infrastructure, inspection, intend, intended, intense, intrinsic, introduction, involve, issuable, Issuer, labeling, laboratory, liability, magnitude, mandating, manner, medical, multiple, notification, occurrence, offered, offering, oncology, opportunity, partial, partially, patient, placement, portrayal, premarket, proficiency, promulgated, prosecution, qualification, quality, recall, receipt, redemption, regulatory, reliability, remaining, resale, seizure, sheet, sophisticated, strategic, successful, Summary, system, train, unannounced, uncertainty, undelivered, upfront, valuation, vitro, warrant, withdrawal

Removed: accrued, acquisition, actively, advertising, agreed, allegedly, alleging, appeal, appealed, begun, bid, Blech, breach, building, ceasing, Circuit, commercialized, comparing, complaint, controlling, Court, CV, David, delisted, detection, developed, dismissal, District, dye, Edward, established, expenditure, fall, fewer, file, Finally, fluorescent, fourth, funded, hearing, incentive, informed, instituted, Jofen, joint, launched, leave, lesser, letter, liquid, liquidity, listed, listing, marketplace, mediation, Mordecai, motion, Nasdaq, November, obligated, previously, print, reagent, recharacterized, relisted, representing, satisfy, secure, settlement, Silicon, SmallCap, Southern, thereon, traded, Trust, Trustee, twelve, Valley, viewed, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

EBIO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, William G. Gerber, President and Chief Executive Officer of Epoch Biosciences, Inc. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)		the Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(2)		the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 10, 2004	By:	/s/ William G. Gerber
		William G. Gerber
		President and Chief Executive Officer